BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26897666)

  • 21. [The best of valvular heart disease in 2006].
    de Gevigney G;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin's lymphoma.
    Cella L; Liuzzi R; Conson M; Torre G; Caterino M; De Rosa N; Picardi M; Camera L; Solla R; Farella A; Salvatore M; Pacelli R
    Radiother Oncol; 2011 Nov; 101(2):316-21. PubMed ID: 21925755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valvular manifestations of human immunodeficiency virus infection--results from the prospective, multicenter HIV-HEART study.
    Reinsch N; Esser S; Gelbrich G; Brockmeyer N; Potthoff A; Schadendorf D; Erbel R; Neumann T
    J Cardiovasc Med (Hagerstown); 2013 Oct; 14(10):733-9. PubMed ID: 24335884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study.
    Majhail NS; Ness KK; Burns LJ; Sun CL; Carter A; Francisco L; Forman SJ; Bhatia S; Baker KS
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1153-9. PubMed ID: 17889351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults.
    Hequet O; Le QH; Moullet I; Pauli E; Salles G; Espinouse D; Dumontet C; Thieblemont C; Arnaud P; Antal D; Bouafia F; Coiffier B
    J Clin Oncol; 2004 May; 22(10):1864-71. PubMed ID: 15143078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anthracycline-induced cardiac toxicity more likely in underweight childhood cancer survivors.
    Andolina JR; Dilley K
    J Pediatr Hematol Oncol; 2010 Jul; 32(5):411-5. PubMed ID: 20495481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas.
    Auriemma RS; Pivonello R; Perone Y; Grasso LF; Ferreri L; Simeoli C; Iacuaniello D; Gasperi M; Colao A
    Eur J Endocrinol; 2013 Sep; 169(3):359-66. PubMed ID: 23824978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No evidence of a detrimental effect of cabergoline therapy on cardiac valves in patients with acromegaly.
    Maione L; Garcia C; Bouchachi A; Kallel N; Maison P; Salenave S; Young J; Assayag P; Chanson P
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1714-9. PubMed ID: 22723314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Echocardiographic determination of the prevalence of primary myxomatous degeneration of the cardiac valves.
    He Y; Guo Y; Li Z; Chen J; Kontos MC; Paulsen WH; Han J; Wang L; Gu X; Nixon JV
    J Am Soc Echocardiogr; 2011 Apr; 24(4):399-404. PubMed ID: 21353473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilization of Cardiac Surveillance Tests in Survivors of Breast Cancer and Lymphoma After Anthracycline-Based Chemotherapy.
    Ruddy KJ; Sangaralingham LR; Van Houten H; Nowsheen S; Sandhu N; Moslehi J; Neuman H; Jemal A; Haddad TC; Blaes AH; Villarraga HR; Thompson C; Shah ND; Herrmann J
    Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005984. PubMed ID: 32106704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy.
    Tsai HR; Gjesdal O; Wethal T; Haugaa KH; Fosså A; Fosså SD; Edvardsen T
    Am J Cardiol; 2011 Feb; 107(3):472-7. PubMed ID: 21257017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.
    Haugnes HS; Wethal T; Aass N; Dahl O; Klepp O; Langberg CW; Wilsgaard T; Bremnes RM; Fosså SD
    J Clin Oncol; 2010 Oct; 28(30):4649-57. PubMed ID: 20855830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of frontline autologous stem cell transplantation in young, high-risk diffuse large B-cell lymphoma patients.
    Yoon JH; Kim JW; Jeon YW; Lee SE; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Park CW; Cho SG
    Korean J Intern Med; 2015 May; 30(3):362-71. PubMed ID: 25995667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia.
    Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Andresen S; Kuczkowski E; Bolwell B
    J Clin Oncol; 2006 Aug; 24(22):3604-10. PubMed ID: 16877727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010.
    Larsen CM; Garcia Arango M; Dasari H; Arciniegas Calle M; Adjei E; Rico Mesa J; Scott CG; Thompson CA; Cerhan JR; Haddad TC; Goetz MP; Herrmann J; Villarraga HR
    JAMA Netw Open; 2023 Feb; 6(2):e2254669. PubMed ID: 36735254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation.
    Ebeling PR; Thomas DM; Erbas B; Hopper JL; Szer J; Grigg AP
    J Bone Miner Res; 1999 Mar; 14(3):342-50. PubMed ID: 10027899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation.
    Armenian SH; Sun CL; Shannon T; Mills G; Francisco L; Venkataraman K; Wong FL; Forman SJ; Bhatia S
    Blood; 2011 Dec; 118(23):6023-9. PubMed ID: 21976673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obstructive and restrictive pulmonary dysfunction in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation.
    Stenehjem JS; Smeland KB; Murbraech K; Holte H; Kvaløy SO; Wethal T; Kiserud CE; Samersaw-Lund MB
    Acta Oncol; 2018 Jun; 57(6):773-781. PubMed ID: 29171324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired exercise capacity and left ventricular function in long-term adult survivors of childhood acute lymphoblastic leukemia.
    Christiansen JR; Kanellopoulos A; Lund MB; Massey R; Dalen H; Kiserud CE; Ruud E; Aakhus S
    Pediatr Blood Cancer; 2015 Aug; 62(8):1437-43. PubMed ID: 25832752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.
    Leger K; Slone T; Lemler M; Leonard D; Cochran C; Bowman WP; Bashore L; Winick N
    Pediatr Blood Cancer; 2015 Jan; 62(1):123-7. PubMed ID: 25176022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.